Clinical Trials Logo

Clinical Trial Summary

The mobilization of natural killer cells (uNK) triggers and coordinates all stages of embryo implantation. They are at the origin of the local secretion of cytokines, growth factors, chemokines affecting vascular development and the local immunotrophisme for the conceptus. The main objective of this study is to evaluate the expression of endometrial uNK cells before and after tubal obstruction by Essure devices. Endoluminal and endometrial levels of various cytokines and growth factors will also be studied.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01558882
Study type Observational
Source Centre Hospitalier Universitaire de Nimes
Contact
Status Terminated
Phase N/A
Start date January 21, 2014
Completion date November 28, 2014

See also
  Status Clinical Trial Phase
Completed NCT02165709 - Cohort Study of Risk Reducing Salpingectomy N/A
Completed NCT03761862 - Evaluation of the Neural Therapy Effect on Long Term Postoperative Discomforts in Patients Who Undergo Bilateral Tubal Ligation
Completed NCT04332120 - Comparison of Results of Different Surgical Techniques Used in Female Tubal Sterilization N/A
Completed NCT03830502 - Driving Factors of Decision Making for Prophylactic Salpingectomy Versus Tubal Ligation at the Time of Cesarean Section
Completed NCT02944149 - Safety of Minilaparotomy Provided by Trained Clinical Officers and Assistant Medical Officers: a Non-inferiority Trial N/A